Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, May 27, 2026, inter alia to: 1. Consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026. 2. Recommend dividend, if any, on the Equity Shares of the Company for the financial year ended March 31, 2026. This is to further inform you that in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the ''Trading Window' for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from April 1, 2026, till 48 hours after declaration of Audited Financial Results on May 27, 2026. Kindly take the above information on your records.
